Single dose of psilocybin for depression shows promising results in UK's first publicly funded randomized trial

The first randomized controlled trial in the U.K. has found that a single dose of psilocybin, the active compound found in "magic mushrooms," produced significant improvements in depression compared with a placebo. This is the first publicly funded randomized trial of its kind to deliver the treatment within an NHS setting in England, and it found promising results.